Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZY021 vs Xiongdan Jiaonang for acute conjunctivitis
CTR20211717Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZY021 in conjunctivitis, sponsored by Shanghai Institute of Materia Medica. Started Jul 2021; status: completed.
02
Drugs
ZY021
03
Conditions
conjunctivitis
Beyond the preview
Go deeper on CTR20211717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211717.